Literature DB >> 31771987

Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial.

Inge Henselmans1,2,3, Hanneke W M van Laarhoven4,3, Pomme van Maarschalkerweerd5, Hanneke C J M de Haes5, Marcel G W Dijkgraaf6, Dirkje W Sommeijer4,7, Petronella B Ottevanger8, Helle-Brit Fiebrich9, Serge Dohmen10, Geert-Jan Creemers11, Filip Y F L de Vos12, Ellen M A Smets5,2,3.   

Abstract

BACKGROUND: Palliative systematic treatment offers uncertain and often limited benefits, and the burden can be high. Hence, treatment decisions require shared decision making (SDM). This trial examined the independent and combined effect of an oncologist training and a patient communication aid on SDM.
METHODS: In this multicenter randomized controlled trial with four parallel arms (2016-2018), oncologists (n = 31) were randomized to receive SDM communication skills training or not. The training consisted of a reader, two group sessions, a booster session, and a consultation room tool (10 hours). Patients (n = 194) with advanced cancer were randomized to receive a patient communication aid or not. The aid consisted of education on SDM, a question prompt list, and a value clarification exercise. The primary outcome was observed SDM as rated by blinded observers from audio-recorded consultations. Secondary outcomes included patient-reported SDM, patient and oncologist satisfaction, patients' decisional conflict, patient quality of life 3 months after consultation, consultation duration, and the decision made.
RESULTS: The oncologist training had a large positive effect on observed SDM (Cohen's d = 1.12) and on patient-reported SDM (d = 0.73). The patient communication aid did not improve SDM. The combination of interventions did not add to the effect of training oncologists only. The interventions affected neither patient nor oncologist satisfaction with the consultation nor patients' decisional conflict, quality of life, consultation duration, or the decision made.
CONCLUSION: Training medical oncologists in SDM about palliative systemic treatment improves both observed and patient-reported SDM. A patient communication aid does not. The incorporation of skills training in (continuing) educational programs for medical oncologists is likely to stimulate the widely advocated uptake of shared decision making in clinical practice. Trial registration. Netherlands Trial Registry NTR 5489. IMPLICATIONS FOR PRACTICE: Treatment for advanced cancer offers uncertain and often small benefits, and the burden can be high. Hence, treatment decisions require shared decision making (SDM). SDM is increasingly advocated for ethical reasons and for its beneficial effect on patient outcomes. Few initiatives to stimulate SDM are evaluated in robust designs. This randomized controlled trial shows that training medical oncologists improves both observed and patient-reported SDM in clinical encounters (n = 194). A preconsultation communication aid for patients did not add to the effect of training oncologists. SDM training effectively changes oncologists' practice and should be implemented in (continuing) educational programs.
© 2019 The Authors. The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.

Entities:  

Keywords:  Advanced cancer; Communication skills training; Doctor‐patient communication; Palliative medicine; Patient education; Patient participation; Shared decision making; Systemic treatment

Year:  2019        PMID: 31771987     DOI: 10.1634/theoncologist.2019-0453

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  68 in total

1.  Analyzing Repeated Measurements Using Mixed Models.

Authors:  Michelle A Detry; Yan Ma
Journal:  JAMA       Date:  2016-01-26       Impact factor: 56.272

Review 2.  Shared decision making: developing the OPTION scale for measuring patient involvement.

Authors:  G Elwyn; A Edwards; M Wensing; K Hood; C Atwell; R Grol
Journal:  Qual Saf Health Care       Date:  2003-04

3.  The decisional conflict scale: further validation in two samples of Dutch oncology patients.

Authors:  N Koedoot; S Molenaar; P Oosterveld; P Bakker; A de Graeff; M Nooy; I Varekamp; H de Haes
Journal:  Patient Educ Couns       Date:  2001-12-01

4.  When the treatment goal is not cure: are cancer patients equipped to make informed decisions?

Authors:  Melina Gattellari; Katie J Voigt; Phyllis N Butow; Martin H N Tattersall
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

5.  Development and evaluation of a decision aid for patients with stage IV non-small cell lung cancer.

Authors:  Valerie Fiset; Annette M. O'Connor; William Evans; Ian Graham; Catherine Degrasse; Jo Logan
Journal:  Health Expect       Date:  2000-06       Impact factor: 3.377

6.  The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample.

Authors:  Levente Kriston; Isabelle Scholl; Lars Hölzel; Daniela Simon; Andreas Loh; Martin Härter
Journal:  Patient Educ Couns       Date:  2009-10-30

Review 7.  Patient centered decision making in palliative cancer treatment: a world of paradoxes.

Authors:  Hanneke de Haes; Nelleke Koedoot
Journal:  Patient Educ Couns       Date:  2003-05

8.  A qualitative analysis of responses to a question prompt list and prognosis and end-of-life care discussion prompts delivered in a communication support program.

Authors:  Adam Walczak; Inge Henselmans; Martin H N Tattersall; Josephine M Clayton; Patricia M Davidson; Jane Young; Frances A Bellemore; Ronald M Epstein; Phyllis N Butow
Journal:  Psychooncology       Date:  2014-07-30       Impact factor: 3.894

9.  Dutch Translation and Psychometric Testing of the 9-Item Shared Decision Making Questionnaire (SDM-Q-9) and Shared Decision Making Questionnaire-Physician Version (SDM-Q-Doc) in Primary and Secondary Care.

Authors:  Sumayah Rodenburg-Vandenbussche; Arwen H Pieterse; Pieter M Kroonenberg; Isabelle Scholl; Trudy van der Weijden; Gre P M Luyten; Roy F P M Kruitwagen; Henk den Ouden; Ingrid V E Carlier; Irene M van Vliet; Frans G Zitman; Anne M Stiggelbout
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

Review 10.  Clarifying values: an updated review.

Authors:  Angela Fagerlin; Michael Pignone; Purva Abhyankar; Nananda Col; Deb Feldman-Stewart; Teresa Gavaruzzi; Jennifer Kryworuchko; Carrie A Levin; Arwen H Pieterse; Valerie Reyna; Anne Stiggelbout; Laura D Scherer; Celia Wills; Holly O Witteman
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-29       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.